<p><h1>Sodium Iodide (131I) Therapy Capsules Market Research Report Reveals The Latest Trends And Opportunities of this Market for Period from 2025 - 2032</h1></p><p><strong>Sodium Iodide (131I) Therapy Capsules Market Analysis and Latest Trends</strong></p>
<p><p>Sodium Iodide (131I) Therapy Capsules are a form of radiopharmaceutical treatment primarily used for hyperthyroidism and thyroid cancer. The capsules emit beta radiation, enabling targeted therapy that minimizes damage to surrounding tissues. Their effectiveness and precision in treating thyroid-related disorders have increased their adoption in clinical settings.</p><p>The Sodium Iodide (131I) Therapy Capsules Market is expected to grow at a CAGR of 14% during the forecast period, driven by rising incidences of thyroid disorders and advancements in nuclear medicine. Increased awareness and early diagnosis of thyroid conditions have led to a greater demand for effective treatment options. Additionally, ongoing research and the development of new therapeutic uses for sodium iodide are expanding the market.</p><p>Key trends influencing the market include the integration of innovative drug delivery technologies, enhanced manufacturing processes, and a growing inclination towards personalized medicine. As healthcare facilities adopt more sophisticated diagnostic tools, the demand for radiopharmaceuticals like Sodium Iodide (131I) is expected to surge. Collaborations between pharmaceutical companies and research institutions are also facilitating breakthroughs and expanding the therapeutic applications of these capsules, further fueling market growth.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchiq.com/enquiry/request-sample/2895030?utm_campaign=2840&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-therapy-capsules">https://www.reliableresearchiq.com/enquiry/request-sample/2895030</a></p>
<p>&nbsp;</p>
<p><strong>Sodium Iodide (131I) Therapy Capsules Major Market Players</strong></p>
<p><p>The Sodium Iodide (131I) therapy capsules market is characterized by several key players, each contributing uniquely to the industry's growth. Notable companies include Curium Pharma, HTA Co., Ltd., Jubilant Pharmova, PDRadiopharma Inc., Yantai Dongcheng Pharmaceutical Group, NTP Radioisotopes, International Isotopes Inc., ANSTO, POLATOM (NCBJ), and Isotope JSC (Rosatom).</p><p>Curium Pharma is a prominent player, focusing on expanding its product portfolio in radiopharmaceuticals. The company is well-positioned for growth due to increasing applications of Sodium Iodide in treating thyroid disorders. Similarly, Jubilant Pharmova has been scaling its operations, benefitting from strategic partnerships that enhance its distribution capabilities, and it reported a revenue of approximately $1 billion across its pharmaceutical divisions.</p><p>NTP Radioisotopes has witnessed steady growth driven by advancements in radiotherapy and diagnostic applications. It plays a significant role in providing high-quality radiopharmaceuticals across international markets. Meanwhile, International Isotopes Inc. is diversifying its offerings and has recently expanded production facilities, which should bolster its market position.</p><p>Yantai Dongcheng Pharmaceutical Group is a key competitor in the Chinese market, capitalizing on the growing demand for radiopharmaceuticals in Asia. The company has established a strong distribution network, enhancing its access to various healthcare providers.</p><p>Overall, the Sodium Iodide (131I) market is projected to grow, influenced by increasing thyroid cancer cases and advancements in radiopharmaceutical technologies. The global market size is estimated to be valued at several hundred million dollars, with expectations for continued growth driven by an aging population and rising awareness of therapeutic innovations. As these companies expand and innovate, they are likely to capture a significant share of this evolving market.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Sodium Iodide (131I) Therapy Capsules Manufacturers?</strong></p>
<p><p>The Sodium Iodide (131I) therapy capsules market is poised for robust growth, driven by the rising prevalence of thyroid disorders and an increasing shift towards targeted radiotherapy. Key trends include advancements in capsule formulation and delivery methods, enhancing patient compliance. Growing awareness about nuclear medicine and supportive regulatory frameworks further bolster market expansion. Emerging markets present new growth opportunities as healthcare infrastructure improves. The market is anticipated to witness CAGR of approximately 5-7% over the next five years, supported by ongoing research and development initiatives. Collaboration between pharmaceutical companies and healthcare providers will be crucial for future advancements.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchiq.com/enquiry/pre-order-enquiry/2895030?utm_campaign=2840&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-therapy-capsules">https://www.reliableresearchiq.com/enquiry/pre-order-enquiry/2895030</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Sodium Iodide (131I) Therapy Capsules Market Analysis by types is segmented into:</strong></p>
<p><ul><li><600MBq</li><li>600MBq-2000MBq</li><li>>2000MBq</li></ul></p>
<p><p>Sodium Iodide (131I) therapy capsules are categorized based on their radioactivity levels, which influence their medical applications. The <600MBq segment is typically used for low-dose treatments, such as hyperthyroidism. The 600MBq-2000MBq range serves moderate therapeutic needs, often in thyroid cancer management. Finally, the >2000MBq category addresses high-dose treatments for advanced cancer and other severe thyroid conditions. These classifications help healthcare providers select appropriate doses for optimal patient outcomes and safety during radioactive iodine therapy.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchiq.com/purchase/2895030?utm_campaign=2840&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-therapy-capsules">https://www.reliableresearchiq.com/purchase/2895030</a></p>
<p>&nbsp;</p>
<p><strong>The Sodium Iodide (131I) Therapy Capsules Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hyperthyroidism Treatment</li><li>Thyroid Cancer Treatment</li></ul></p>
<p><p>Sodium Iodide (131I) therapy capsules are utilized primarily for treating hyperthyroidism and thyroid cancer. In hyperthyroidism, these capsules help to selectively destroy overactive thyroid tissue, reducing excessive hormone production. For thyroid cancer, 131I enables targeted therapy by delivering radiation to cancerous cells, minimizing damage to surrounding healthy tissues. The market for these therapies is growing due to increasing thyroid-related disorders, advancements in treatment protocols, and rising awareness among patients and healthcare providers about the effectiveness of radioactive iodine therapy.</p></p>
<p><a href="https://www.reliableresearchiq.com/sodium-iodide-131i-therapy-capsules-r2895030?utm_campaign=2840&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-therapy-capsules">&nbsp;https://www.reliableresearchiq.com/sodium-iodide-131i-therapy-capsules-r2895030</a></p>
<p><strong>In terms of Region, the Sodium Iodide (131I) Therapy Capsules Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The Sodium Iodide (131I) therapy capsules market is witnessing substantial growth across various regions, with North America and Europe leading in market share due to advanced healthcare infrastructure and increasing cancer prevalence. North America holds a significant share at approximately 40%, followed by Europe at 30%. Asia-Pacific, particularly China, is emerging rapidly, expected to capture 20% of the market due to rising healthcare investments. The remaining 10% comprises other global regions. Enhanced accessibility and awareness are anticipated to drive future demand.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchiq.com/purchase/2895030?utm_campaign=2840&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-therapy-capsules">https://www.reliableresearchiq.com/purchase/2895030</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchiq.com/enquiry/request-sample/2895030?utm_campaign=2840&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-therapy-capsules">https://www.reliableresearchiq.com/enquiry/request-sample/2895030</a></p>
<p><strong></strong></p>
<p><p><a href="https://github.com/tszkintruca/Market-Research-Report-List-1/blob/main/excipients-for-orally-disintegrating-tablets-odt-market.md?utm_campaign=2840&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-therapy-capsules">Excipients for Orally Disintegrating Tablets (ODT) Market</a></p></p>